Researchers at UTHealth Houston and collaborating institutions reported that they restored the function of neurons tied to cognition and information processing in mice engineered to mimic key features of Alzheimer's disease. The work, led by first author Keran Ma, PhD, points toward a possible targeted therapy, though the results so far come from animals.
The study centers on gamma oscillations, rapid electrical rhythms the brain produces during learning, memory formation and information processing. Parvalbumin interneurons, also called PV cells, are the cells primarily responsible for generating those rhythms. The source material notes that gamma oscillations are already disrupted in people with Alzheimer's, and that these disruptions appear even before diagnosis, when patients show signs such as mild cognitive impairment. Early in the disease, the disrupted rhythms come alongside progressive dysfunction of PV cells.
Ma's team found two things. First, PV cell function could be restored by giving the mice a sodium channel subunit, and when that happened, the mice showed improved gamma oscillations. Second, the researchers found that PV cells do not all fire together as previously assumed. Instead, Ma described them being recruited in sequence, with a specific pattern and timing that initiates and sustains gamma activity.
The mice were given the human version of an amyloid protein that leads to amyloid plaque buildup, reproducing a hallmark of the human disease. Ma said the restored recruitment pattern and improved gamma activity show that PV interneurons can be manipulated to increase gamma oscillations, which she called proof of principle. Authors from the Gladstone Institute of Neurological Disease and the Allen Institute for Brain Science also contributed to the work.